Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2005
05/19/2005CA2544207A1 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
05/18/2005CN1617883A Solid salts of benzazepine compounds and pharmaceutical compositions containing them
05/18/2005CN1617881A Chemical process
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide
05/17/2005US6894028 Use of KPV tripeptide for dermatological disorders
05/12/2005WO2005042567A1 Rapamycin peptides conjugates: synthesis and uses thereof
05/12/2005WO2005042560A2 Non-viral delivery of compounds to mitochondria
05/12/2005WO2005042531A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates
05/12/2005WO2005041882A2 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
05/12/2005WO2004108938A3 Peptide ligands of dendritic cells for nucleic acid vector targeting
05/12/2005WO2004103270A3 Compounds and methods for treatment of thrombosis
05/12/2005WO2004018502A8 Compounds binding to p-selectin
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
05/12/2005US20050101764 Process for the preparation of peptides
05/12/2005US20050101664 Anionically coupling an acyl imidazoyl carbamate with a primary amide or carbamate; N-alkylation; inosine-5*-monophosphate dehydrogenase inhibitors
05/12/2005US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester
05/12/2005US20050101540 STAT modulators
05/12/2005US20050101539 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
05/12/2005US20050101538 particularly Alzheimer's disease and mild cognitive impairment; neurotrophines
05/12/2005US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response
05/12/2005US20050099595 Translating bifocal wear modality
05/12/2005CA2544731A1 Rapamycin peptides conjugates: synthesis and uses thereof
05/11/2005EP1529837A2 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
05/11/2005EP1529057A2 Biphalin derivatives and their analgesic applications
05/11/2005EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
05/11/2005EP1165541B1 Dimeric compounds and as inhibitors of neuraminidase
05/11/2005EP1076563B1 Dipeptide caspase inhibitors and the use thereof
05/11/2005CN1615148A Methods and compositions for derepression of IAP-inhibited caspase
05/11/2005CN1615131A Method for identification of tumor targeting enzymes
05/11/2005CN1200947C Method for producing cyclo-(Asp-Dphe-NMeVal-Arg-Gly)
05/11/2005CN1200946C Process for preparation of N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline
05/10/2005US6890896 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/10/2005US6890529 Edible foods, functional products or pharmaceuticals; nutraceutical; beverages
05/06/2005WO2005040198A1 A binding motif and methods of regulating cell function
05/06/2005WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors
05/06/2005WO2004080418A3 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
05/06/2005WO2003018606A3 Casein derived peptides and uses thereof in therapy
05/05/2005US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss
05/05/2005US20050095248 Use of inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
05/05/2005US20050095241 Estrogen receptor modulators and uses thereof
05/05/2005US20050095198 Annexin derivatives with endogenous chelation sites
05/04/2005EP1527086A1 Compounds binding to p-selectin
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005EP1526896A1 Antibacterial ester macrocycles
05/04/2005EP1042964B1 Sweetener composition
05/04/2005CN1612893A VEGF peptides and their use for inhibiting angiogenesis
05/04/2005CN1612892A Novel peptide having angiotensin convertase inhibitory effect
05/04/2005CN1611595A Synthesis of glutathion from Dunaliella saline
05/04/2005CN1199988C Liquid-phase synthesis process of octrotide acetate
05/04/2005CN1199987C Basic monocyclic compounds having NK2 antagonist action, processes for their preparation and formulations containing them
05/04/2005CN1199986C Trivalent iron porphrin and its derivative-short peptide compound and its synthesis
05/03/2005US6888022 Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
05/03/2005US6888007 Stable crystal structure; thrombin inhibitor
05/03/2005US6887887 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor
05/03/2005US6887468 Antibody kits for selectively inhibiting VEGF
04/2005
04/28/2005WO2005037860A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
04/28/2005WO2005037854A2 Immunogenic peptides
04/28/2005WO2005001023A3 Method and carrier complexes for delivering molecules to cells
04/28/2005WO2004110390A3 Anti-cd74 immunoconjugates and methods
04/28/2005WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto
04/28/2005WO2003092631A3 Cyclic peptide anti-viral agents and methods
04/28/2005US20050090449 treating neurodegenerative diseases by administering drugs that inhibit beta-secretase-mediated cleavage of amyloid precursor proteins
04/28/2005US20050090446 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
04/28/2005US20050090432 Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus
04/28/2005US20050089493 Spermine peptide surfactants with amide or amine bonds for surfactants used to transfer cells
04/28/2005CA2541634A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
04/27/2005EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei
04/27/2005EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins
04/27/2005EP0910572B1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
04/27/2005CN1198936C Alzheimer's disease secretase
04/27/2005CN1198839C Novel dipeptide amidines as thrombin inhibitors
04/27/2005CN1198838C Antipicornaviral compounds, their prepn. and use
04/26/2005US6884910 Uses for amino acid anticonvulsants
04/26/2005US6884878 Neuropeptides and their use for pest control
04/26/2005US6884869 Pentapeptide compounds and uses related thereto
04/26/2005US6884782 Amino acid containing compounds useful as modulators of the immune system
04/26/2005CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors
04/21/2005WO2005035525A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
04/21/2005WO2005034982A1 Cyclic peptide antitumor agents
04/21/2005WO2005034981A1 Dipeptide phenyl ethers
04/21/2005WO2005023857A3 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
04/21/2005WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
04/21/2005US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
04/21/2005US20050085425 Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
04/21/2005US20050085424 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
04/21/2005US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth
04/20/2005EP1524272A1 Growth hormone secretagogues
04/20/2005EP1523504A2 A tissue factor binding immunoconjugate comprising factor viia
04/20/2005EP1523493A1 Novel tubulysin analogues
04/20/2005EP1523323A2 Reagents and methods for smooth muscle therapies
04/20/2005EP1318829B1 Angiogenic tri- or tetrapeptides derived from AcSDKP
04/20/2005EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
04/20/2005EP0989994B1 Streptogramines, their preparation and compositions containing them
04/20/2005CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation
04/20/2005CN1197956C Lactobacillus helvetius producing antihypertensive di- and tripeptides
04/14/2005WO2005033307A1 Novel refolding method and protein obtained by the method
04/14/2005WO2005033267A2 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
04/14/2005WO2005033129A1 Antibacterial amide macrocycles
04/14/2005WO2005033128A1 Method for the synthesis of n-[(s)-1-carbethoxybutyl]-(s)-alanine and use thereof for the synthesis of perindopril